Amylyx Pharmaceuticals, Inc. AMLX 深 滬
已收盤 10-16 16:00:00 美东时间
26.34
-1.310
-4.74%
華盛通- 最 高27.65
- 今 開27.65
- 成交量 115.06万股
- 最 低 26.20
- 昨 收 27.65
- 總市值 33.06亿
- 52周最高 41.14
- 市盈率 靜 --
- 換手率 0.92%
- 52周最低 10.83
- 委 比 47.36%
- 總股本 1.26亿
- 歷史最高 41.9297
- 量 比 1.01
- 振 幅 5.24%
- 歷史最低 1.575
- 每 手 1
- 風險率 6.88%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅279.75%！Jones Trading维持Contineum Therapeutics(CTNM)"买入"评级，目标价上调至30美元
今日重点评级关注：Jones Trading：维持Contineum Therapeutics"买入"评级，目标价从24美元升至30美元；StoneX：维持Forum Markets"投机性买入"评级，目标价从9美元升至12美元
10-16 12:30
Citigroup Maintains Buy on Amylyx Pharmaceuticals, Raises Price Target to $39
Citigroup analyst Geoff Meacham maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Buy and raises the price target from $32 to $39.
10-16 00:53
Amylyx Pharma To Present Phase 3 Topline Data Highlighting Avexitide’s Efficacy And Safety At ObesityWeek 2026 Annual Meeting
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) ("Amylyx" or the "Company") today announced it will present two presentations at the upcoming ObesityWeek® 2026 Annual Meeting, taking place November 14-17, 2026, in Washington, D.C. The first late-breaking oral presentation will feature topline results fro...
10-06 20:07
美股大行评级 | 潜在涨幅1024.26%！Ascendiant Capital上调PAVmed目标价至57美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持PAVmed"买入"评级，目标价从56美元升至57美元；Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从9.25美元升至9.5美元
08-28 16:15
Guggenheim Maintains Buy on Amylyx Pharmaceuticals, Raises Price Target to $57
Guggenheim analyst Seamus Fernandez maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Buy and raises the price target from $55 to $57.
08-27 21:45
美股周涨跌榜 | 研发mRNA癌症疫苗获华尔街齐看好！Moderna周涨129%；MSTR周涨28%
研发mRNA癌症疫苗获华尔街齐看好！Moderna周涨129%；AMLX周涨78%，全球首创GLP-1R拮抗剂三期临床试验成功；比特币大幅反弹突破7.8万美元！MSTR周涨28%>>
08-22 10:20
美股牛股 | 医药股AMLX飙升63%，全球首创GLP-1R拮抗剂三期临床试验成功；WEAV劲升31%
医药股AMLX飙升63%，全球首创GLP-1R拮抗剂三期临床试验成功；WEAV劲升31%，获私募巨头溢价34%收购；CDNL升逾15%，高管近日增持320万美元股份>>
08-19 16:11
Why Flexsteel Industries Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Shares of Flexsteel Industries Inc (NASDAQ:FLXS) rose sharply in pre-market trading as the company posted better-than-expected fourth-quarter financial results. The company reported quarterly earnings of $1.33 per share, which beat the analyst consensus estimate of $1.09 per share. The company repor...
08-18 17:01
美股大行评级 | 潜在涨幅455.56%！Cardiol Therapeutics获Canaccord Genuity上调目标价至10美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Cardiol Therapeutics"买入"评级，目标价从8美元升至10美元；B. Riley证券：维持Macrogenics"买入"评级，目标价从9美元升至11美元
08-18 11:39
Amylyx Pharmaceuticals Stock Soars After the Close: Here's Why
Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) shares are trading higher in Monday’s after-hours session after the company scheduled a Phase 3 trial results readout for this week. Amylyx Pharmaceuticals shares are testing new highs. What’s driving AMLX to record levels? Amylyx Pharma Announces Phase 3 LUC...
08-18 04:53
